16 min listen
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
ratings:
Length:
65 minutes
Released:
Mar 3, 2021
Format:
Podcast episode
Description
Dr Mark Pegram from the Stanford University School of Medicine discusses the latest clinical data on and optimal use of newly approved therapies for HER2-positive metastatic breast cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2MetastaticBC21).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2MetastaticBC21).
Released:
Mar 3, 2021
Format:
Podcast episode
Titles in the series (100)
COVID-19 and Prostate Cancer: COVID-19 and prostate cancer treatment with Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor. by Oncology Today with Dr Neil Love